Impact of COVID-19 Outbreak on Autoimmune Disease Drug Market : Trend, CAGR Status, Growth, Analysis and Forecast to 2025 : F. Hoffmann-La Roche, Abbott Laboratories, Bristol-Myers Squibb Company, Amgen, Johnson & Johnson, AstraZeneca, Pfizer, & Nova
Autoimmune Disease Drug Market (Indication - Diabetes Mellitus Type 1, Rheumatic Diseases, Multiple Sclerosis, Rare Diseases, and Other Indication; Drug Class - NSAIDs, Anti-inflammatory, Interferons, Antihyperglycemic, Immunosuppressants, and Other Drug Class; Distribution Channel - Hospital Pharmacies, Online Stores, and Retail Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025
View full press release